CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
67 hedge funds and large institutions have $59.6M invested in CASI Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.93% more ownership
Funds ownership: 2.27% → 3.2% (+0.93%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
67
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$13M | |
| 2 | +$12.4M | |
| 3 | +$1.21M | |
| 4 |
Renaissance Technologies
New York
|
+$1.08M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$942K |
Top Sellers
| 1 | -$200K | |
| 2 | -$74.4K | |
| 3 | -$73K | |
| 4 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$65K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$64K |